SCHEMBL28853231

SCHEMBL28853231

[CH2]Cc1ccnc(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
KMT2A Q03164 4/20 0.42
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 5/20 0.40
RAB9A P51151 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
POLB P06746 2/20 0.40
TRPV3 Q8NET8 2/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
MAPK1 P28482 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7968990 0.81 KMT2A (0.42) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL7958916 0.81 TRPV3 (0.45) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL6409488 0.81 ADRB2 (0.46) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL27135558 0.81 MAPT (0.42) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL5139622 0.80 IDH1 (0.41) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL27775433 0.80 PIK3CA (0.52) CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3260707 0.79 NR1H2 (0.46) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL4101559 0.78 SREBF2 (0.48) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL14351990 0.78 HRH1 (0.48) MAPTKMT2AKDM4EMEN1L3MBTL1
SCHEMBL2639519 0.78 NPC1 (0.42) MAPTKMT2AKDM4EMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104640869-B Imidazo thiadiazoles and Imidazopyridazine derivative as proteinase activated receptors 4 (PAR4) inhibitor for treating platelet aggregation 百时美施贵宝公司 2017-12-12 CN disclosed